7 hedge funds and family offices disclose a CRS position in their latest SEC 13F filing — combined $1.07B in market value.
| # | Investor | Fund | Shares | Value | % of Portfolio | Filed |
|---|---|---|---|---|---|---|
| 1 | Egerton Capital | Egerton Capital (UK) LLP | 1,553,012 | $489.0M | 5.31% | 2025-12-31 |
| 2 | Stephen Mandel | Lone Pine Capital LLC | 1,312,938 | $413.4M | 3.04% | 2025-12-31 |
| 3 | Daniel Loeb | Third Point LLC | 215,000 | $132.6M | 2.83% | 2026-06-30 |
| 4 | Ray Dalio | Bridgewater Associates LP | 48,856 | $30.1M | 0.12% | 2026-06-30 |
| 5 | George Soros | Soros Fund Management LLC | 4,308 | $2.7M | 0.03% | 2026-06-30 |
| 6 | Polen Capital | Polen Capital Management LLC | 6,062 | $1.9M | 0.01% | 2025-12-31 |
| 7 | Cathie Wood | ARK Investment Management LLC | 178 | $110K | 0.00% | 2026-06-30 |
As of the latest 13F window, 7 tracked superinvestors hold CRS. The largest disclosed position is Egerton Capital at $489.0M (5.3% of portfolio).
13F filings are due 45 days after each quarter end and capture long-equity positions held by U.S. institutional managers with $100M+ AUM. Use this page to see exactly who is buying CRS, how concentrated each position is, and the implied conviction level relative to the rest of each investor's book.
Key takeaways
7 hedge funds and family offices disclose a CRS position in their latest SEC 13F filing — combined $1.07B in market value.
| # | Investor | Fund | Shares | Value | % of Portfolio | Filed |
|---|---|---|---|---|---|---|
| 1 | Egerton Capital | Egerton Capital (UK) LLP | 1,553,012 | $489.0M | 5.31% | 2025-12-31 |
| 2 | Stephen Mandel | Lone Pine Capital LLC | 1,312,938 | $413.4M | 3.04% | 2025-12-31 |
| 3 | Daniel Loeb | Third Point LLC | 215,000 | $132.6M | 2.83% | 2026-06-30 |
| 4 | Ray Dalio | Bridgewater Associates LP | 48,856 | $30.1M | 0.12% | 2026-06-30 |
| 5 | George Soros | Soros Fund Management LLC | 4,308 | $2.7M | 0.03% | 2026-06-30 |
| 6 | Polen Capital | Polen Capital Management LLC | 6,062 | $1.9M | 0.01% | 2025-12-31 |
| 7 | Cathie Wood | ARK Investment Management LLC | 178 | $110K | 0.00% | 2026-06-30 |
As of the latest 13F window, 7 tracked superinvestors hold CRS. The largest disclosed position is Egerton Capital at $489.0M (5.3% of portfolio).
13F filings are due 45 days after each quarter end and capture long-equity positions held by U.S. institutional managers with $100M+ AUM. Use this page to see exactly who is buying CRS, how concentrated each position is, and the implied conviction level relative to the rest of each investor's book.
Key takeaways
